Evidence map›Paper›PMID 42564829›Full record

ArticleJHLT open2026

Functional recovery and quality-of-life improvement 12 months after LVAD implantation: A single-center cohort.

Mohammed Najdat Seijari, Taraneh Zamani, Ma'in Abumuhfouz, Souwdamini Sethuram, Mohamed Fael, Saadeddine Khayat, Angel Mena, Peter Dinh Tran, Kathryn Lynne O'Keefe, Omar H Jawaid and 3 more

Abstract read
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohammed Najdat SeijariTriHealth Good Samaritan Hospital, Cincinnati, OH.
Taraneh ZamaniTriHealth Good Samaritan Hospital, Cincinnati, OH.
Ma'in AbumuhfouzUniversity of Missouri - Kansas City (UMKC), Kansas City, MO.
Souwdamini SethuramTriHealth Good Samaritan Hospital, Cincinnati, OH.
Mohamed FaelUniversity of Missouri - Kansas City (UMKC), Kansas City, MO.
Saadeddine KhayatTriHealth Good Samaritan Hospital, Cincinnati, OH.
Angel MenaTriHealth Good Samaritan Hospital, Cincinnati, OH.
Peter Dinh TranTriHealth Good Samaritan Hospital, Infectious Diseases Department, Cincinnati, OH.
Kathryn Lynne O'KeefeTriHealth Heart & Vascular Institute, Cincinnati, OH.
Omar H JawaidTriHealth Heart & Vascular Institute, Cincinnati, OH.
Samer KaspoSaint Francis Hospital, Chicago, IL.
Ahmed ChaabanUniversity at Buffalo, New York, NY.
Sateesh KesariTriHealth Heart & Vascular Institute, Cincinnati, OH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Left ventricular assist devices (LVADs) improve survival in advanced heart failure, but the extent of functional and quality-of-life (QoL) recovery remains incompletely characterized. Methods: This single-center retrospective study evaluated 41 LVAD recipients at baseline and 12 months post-implant in a contemporary community-based program, with 95% of implants performed as destination therapy, using standardized instruments (KCCQ-12, EQ-5D-3L, EQ-VAS, 6MWD). Paired statistical testing assessed within-patient changes. Results: KCCQ-12 scores increased from 36.1 ± 11.0-46.1 ± 10.8 (p < 0.001); 6MWD improved from 242 ± 104 m to 320 ± 113 m (p = 0.0054); and EQ-VAS improved from 54.4 ± 23.0-72.6 ± 17.0 (p < 0.001). Domains reflecting enjoyment of life (p = 0.025), ability to perform household chores (p = 0.026), and jogging/hurrying limitation (p = 0.018) all improved significantly. Self-reported stress decreased (6.4 → 4.4; p = 0.002), and satisfaction with HF therapy increased (7.2 → 8.5; p = 0.033). Conclusions: One year after LVAD implantation, patients demonstrated improvements in functional capacity and QoL, underscoring the importance of integrating psychosocial and rehabilitative strategies in LVAD care.

Indexed as

Advanced heart failureFunctional capacityHeartMate 3Left ventricular assist devicePatient-reported outcomesQuality of life

Identifiers

PMID42564829
PMCPMC13446337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.